← Eichor
Study identifier: NCT06395272 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Proprioceptive Sensitivity Stimulation Via the SURA Electrodevice on Kinematics, Kinetics and Spatiotemporal Parameters of Gait.

Condition: Stroke  ·  Sponsor: Facultat de ciencies de la Salut Universitat Ramon Llull

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Recovery of function in people with central nervous system (CNS) injury after stroke is very much like a relearning process that takes advantage of preserved sensorimotor circuits. Relearning can be optimised by providing appropriate proprioceptive (or deep sensory) information to the spinal cord with the aim of maximally engaging the preserved neural circuits. The development of the SURA electrodevice offers this sensitive input mechanism, within the Botton Up therapies. And through research on its use, the impact on the different dimensions related to gait and its components, and the translation to the functional reality of the person, will be evaluated.

This description comes directly from the study's public registry record.

Talk to the study team

Pedro Victor López Plaza  ·  932 53 32 56  ·  pedrovictorlp@blanquerna.url.edu

Always discuss trial participation with your own doctor first.

Locations (1)

CSSV-RifBarcelona, Vilafranca Del Penedés, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06395272